The application relates to pharmaceutical formulation and a process for its preparation. The pharmaceutical formulation comprises cinnamic acid and at least one excipient. The pharmaceutical formulation of the present disclosure has improved patient compliance, and reduced adverse effects. The pharmaceutical formulation of the present disclosure can be used in the treatment of cyclophosphamide induced neutropenia. …
Day: November 10, 2025
Pharmaceutical Compositions Comprising Picroside
The patent discloses a pharmaceutical composition comprising picroside isolated from Picrorrhize kurroa. The composition contains Picroside I as an active ingredient for treating drug-induced immunopathy such as neutropenia. Methods of isolating Picroside I and Picroside II, and preparing the compositions have also been disclosed herein. The said composition of Picroside I can be a solid oral …